{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15875663", "DateCompleted": {"Year": "2006", "Month": "04", "Day": "17"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0513-4870", "JournalIssue": {"Volume": "40", "Issue": "2", "PubDate": {"Year": "2005", "Month": "Feb"}}, "Title": "Yao xue xue bao = Acta pharmaceutica Sinica", "ISOAbbreviation": "Yao Xue Xue Bao"}, "ArticleTitle": "Effects of isoliensinine on proliferation of porcine coronary arterial smooth muscle cells induced by phenylephrine.", "Pagination": {"StartPage": "105", "EndPage": "110", "MedlinePgn": "105-10"}, "Abstract": {"AbstractText": ["To investigate the inhibitory effects and mechanism of action of isoliensinine (IL) on the proliferation of porcine coronary arterial smooth muscle cells (CASMCs) induced by phenylephrine (Phen) and its mechanisms of action.", "MTT assay, immunohistochemical method and Western blotting were adopted.", "IL (0.03 - 3 micromol x L(-1)) could inhibit the CASMCs proliferation induced by Phen (0.1 micromol x L(-1)) in a concentration-dependent manner. IL (0.1 micromol x L(-1)) antagonized Phen-induced overexpression of PDGF-beta and bFGF from 0.545 +/- 0.026 and 0.47 +/- 0.03 to 0.458 +/- 0.019 and 0.376 +/- 0.017 (P < 0.01 , P < 0.01). IL (0.1 micromol x L(-1)) also decreased c-fos, c-myc and hsp70 overexpression induced by Phen from 0.57 +/- 0.04, 0.44 +/- 0.04 and (173 +/- 36)% to 0.46 +/- 0.05, 0.372 +/- 0.021 and (115 +/- 35)% respectively (P < 0.01, P < 0.01, P < 0.01).", "IL exerted antiproliferative effect on CASMCs induced by phenylephrine, and its mechanisms were related to decrease the overexpression of growth factors (PDGF-beta, bFGF), protooncogene (c-fos, c-myc) and hsp70."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Tongji Medical College, Wuhan 430030, China. xiaojunhuacao@yahoo.com.cn"}], "Identifier": [], "LastName": "Xiao", "ForeName": "Jun-hua", "Initials": "JH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Yan-lin", "Initials": "YL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ding", "ForeName": "Li-li", "Initials": "LL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Feng", "ForeName": "Xiu-ling", "Initials": "XL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Jia-ling", "Initials": "JL"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Yao Xue Xue Bao", "NlmUniqueID": "21710340R", "ISSNLinking": "0513-4870"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "HSP70 Heat-Shock Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-fos"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-myc"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-sis"}, {"RegistryNumber": "0", "NameOfSubstance": "isoliensinine"}, {"RegistryNumber": "103107-01-3", "NameOfSubstance": "Fibroblast Growth Factor 2"}, {"RegistryNumber": "1WS297W6MV", "NameOfSubstance": "Phenylephrine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["cytology"], "DescriptorName": "Coronary Vessels"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["metabolism"], "DescriptorName": "Fibroblast Growth Factor 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "HSP70 Heat-Shock Proteins"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacology"], "DescriptorName": "Isoquinolines"}, {"QualifierName": ["cytology"], "DescriptorName": "Muscle, Smooth, Vascular"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nelumbo"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Phenylephrine"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-fos"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-myc"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-sis"}, {"QualifierName": [], "DescriptorName": "Swine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "5", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "4", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "5", "Day": "7", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15875663"]}}], "PubmedBookArticle": []}